版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
1、新疆醫(yī)科大學(xué)碩士學(xué)位論文中晚期宮頸癌動(dòng)脈新輔助化療的臨床分析姓名:潘靜申請(qǐng)學(xué)位級(jí)別:碩士專業(yè):婦產(chǎn)科學(xué)指導(dǎo)教師:姚麗艷2009-04新疆醫(yī)科大學(xué)醫(yī)學(xué)碩士學(xué)位論文 —2—The Clinical analyze of intra- arterial neoadjuvant chemotherapy for Patients with metaphase or advanced cervical carcinoma
2、Postgraduate: Pan Jing Supervisor: Prof. Yao Li Yan Abstract Objective: To investigate the curative effect and clinical meaning of scheme intra- arterial neoadjuvant chemotherapy treated patients with metaph
3、ase or advanced cervical carcinoma. Methods: A retrospective analysis of 67 patiens within cervical carcinoma stage Ib- IIIb in our hospital. To analyze the short- term clinical curative effect, o
4、peration rate, influencing factor and side effect after the Intra- arterial neoadjuvant chemotherapy for the patients with stage IIb- IIIb; to evaluate the feasibility to have the operation with r
5、adical hysterectomy and pelvic lymphadenetomy for patients with metaphase or advanced cervical carcinoma after chemotherapy contrasted with Ib- IIa patients. Results: To a certain degree ,clinical symptom
6、 of patients had relieved, overall remission rate 77%, and the operation rate is 46.7%,there was no significant difference in the short- termeffect rate ,clinical stage and histology with chemo
7、 remission rate between the two groups in stage II and III, (P>0.05). After the neoadjuvant chemotherapy the most patients had light bone marrow depression, liver function and renal function
8、 lesion, and didnot exist severe side reaction. (P0.05). Conclusion: The Intra- arterial neoadjuvant chemotherapy had better recent curative effect and operation rate for patients with metaphase or
9、 advanced cervical carcinoma. It does not increase postoperative complications and the difficult degree of radical hysterectomy and pelvic lymphadenetomy. It is a kind of effective comprehensive t
10、herapy. But,its influence for long- term curative effect and survival rate still need a large number of clinical cases and a long time following up to verify. Keyword: cervical carcinoma; neoad
溫馨提示
- 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 眾賞文庫(kù)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 中晚期宮頸癌術(shù)前及放療前經(jīng)動(dòng)脈新輔助化療的臨床回顧研究系.pdf
- 局部晚期宮頸癌新輔助化療的臨床研究.pdf
- 局部晚期宮頸癌新輔助化療近期臨床療效的觀察.pdf
- 中晚期宮頸癌術(shù)前子宮動(dòng)脈化療栓塞與放療的對(duì)比.pdf
- 同步放化療治療中晚期宮頸癌的臨床療效觀察
- 巨塊型宮頸癌動(dòng)脈介入新輔助化療臨床觀察.pdf
- 子宮動(dòng)脈灌注新輔助化療在Ⅱ期宮頸癌治療中的臨床分析.pdf
- 巨塊型宮頸癌新輔助化療的臨床分析.pdf
- 熱放化療對(duì)中晚期宮頸癌的療效.pdf
- 新輔助化療在局部晚期宮頸癌治療中的應(yīng)用——附86例臨床分析.pdf
- 新輔助化療在局部晚期宮頸癌中的近遠(yuǎn)期療效分析.pdf
- 中晚期子宮頸癌同步放化療的臨床療效觀察.pdf
- 不同化療藥物用于中晚期宮頸癌同步放化療中的臨床觀察.pdf
- 新輔助化療及手術(shù)治療局部晚期宮頸癌60例療效分析
- 介入聯(lián)合放射治療中晚期宮頸癌的臨床回顧分析.pdf
- 15例宮頸癌術(shù)前新輔助化療的臨床應(yīng)用.pdf
- 局部巨塊型宮頸癌新輔助化療臨床觀察.pdf
- 局部晚期宮頸癌新輔助化療后不同手術(shù)入路的對(duì)比分析.pdf
- 新輔助化療在局部晚期宮頸癌治療中的近期療效研究.pdf
- 宮頸癌新輔助化療不同方案的臨床療效觀察.pdf
評(píng)論
0/150
提交評(píng)論